or
forgot password
  • cancer clinical trials in nashville, TN

  • Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
    Vanderbilt -Ingram Cancer Center
    Nashville, Tennessee 37232
    Diffuse Large B-cell Lymphoma
    Evaluation of SJG-136 for Cisplatin- Refractory /Resistant Epithelial Ovarian
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Ovarian Carcinoma
    SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    A Study of CAL-101 and Rituximab in Elderly Patients With Untreated CLL or SLL
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
    Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Graft vs Host Disease, Cutaneous Sclerosis, Bronchiolitis Obliterans
    Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By Surgery
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Stage IA Non-small Cell Lung Cancer, Stage IB Non-small Cell Lung Cancer
    Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Rectal Cancer
    Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Recurrent Thyroid Cancer, Stage I Follicular Thyroid Cancer, Stage I Papillary Thyroid Cancer, Stage II Follicular Thyroid Cancer, Stage II Papillary Thyroid Cancer, Stage III Follicular Thyroid Cancer, Stage III Papillary Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer, Stage IVB Follicular Thyroid Cancer, Stage IVB Papillary Thyroid Cancer, Stage IVC Follicular Thyroid Cancer, Stage IVC Papillary Thyroid Cancer
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

    Nashville, Tennessee 37203-1632
    Prostate Neoplasms, Genital Neoplasms, Male, Urogenital Neoplasms, Genital Diseases, Male
    A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene
    Vanderbilt Univeristy SC

    Trial Locations
    Vanderbilt Univeristy SC
    Sarah Cannon Research Institute Dept.ofSarahCannonCancerCtr(4)
    Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer
    Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Smoldering Multiple Myeloma
    Positron Emission Tomography (PET)-Computed Tomography (CT) PET/CT Evaluation of Treatment Response in Breast Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Breast Cancer
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
    Vanderbilt University Medical Center SC
    Nashville, Tennessee 37232
    Metastatic Renal Cell Carcinoma
    Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Childhood Cancer
    Ceftriaxone in Non-neutropenic Fever
    Monroe Carrell Jr. Children's Hospital at Vanderbilt
    Nashville, Tennessee 37232
    Histiocytosis, Pediatric Patients With Cancer
    A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors
    Tennessee Oncology
    Nashville, Tennessee 37203
    Metastatic or Unresectable Solid Tumor Malignancy
    CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
    Tennessee Oncology Dept. of Centennial Medical
    Nashville, Tennessee 37203
    Chronic Myelogenous Leukemia in Chronic Phase
    Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Fatigue, Hodgkin Lymphoma
    Yoga Intervention for Cancer Survivors
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Cancer Survivors, Yoga
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
    A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
    Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2)
    Nashville, Tennessee 37203
    Advanced Solid Tumor, Lymphomas
    Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Advanced Solid Tumors, Metastatic Colorectal Cancer
    A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
    Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2)
    Nashville, Tennessee 37203
    Solid Tumors
    The Adv Halt Trial
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Adenovirus Disease
    Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
    Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt 3
    Nashville, Tennessee 37212
    Acute Myeloid Leukemia (AML)
    PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Vanderbilt Cool Springs
    Vanderbilt Breast Center One Hundred Oaks
    Metastatic Breast Cancer
    SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
    Tennessee Oncology
    Nashville, Tennessee 37203
    MDS, CMML, AML
    Lapatinib in Stage IV Melanoma With ERBB4 Mutations
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Malignant Melanoma
    IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Metastatic Renal Cell Carcinoma
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Meharry Medical College
    Nashville, Tennessee 37208-3599
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Tumors Metastatic to Brain
    Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma, Marginal Zone Lymphoma
    A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
    Urology Associates, PC
    Nashville, Tennessee 37209
    Prostatic Neoplasms
    Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Advanced Solid Malignant Tumors, Advanced Ovarian Cancer
    Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
    Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center
    Nashville, Tennessee 37232
    GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia, Myelodysplastic Syndrome
    Safety Study of X-82 in Patients With Advanced Solid Tumors
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Advanced Solid Tumors
    Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
    Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt 2
    Nashville, Tennessee 37212
    Non-small Cell Lung Cancer
    A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer

    Nashville, Tennessee 37203-1632
    Metastatic Cancer, Cancer, Solid Tumors
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Head and Neck Cancer, Precancerous Condition
    A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Acute Myeloid Leukemia
    A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    HER-2 Positive Breast Cancer
    A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors

    Nashville, Tennessee 37203-1632
    Advanced Solid Tumors, Locally Advanced or Metastatic Breast or Colorectal Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Vanderbilt University Medical Center

    Trial Locations
    Vanderbilt University Medical Center
    Urology Associates, P.C.
    Advanced Prostate Cancer, Prostatic Neoplasms